NEOVASCULAR AGE RELATED MACULAR DEGENERATION (NAMD): THE EFFECT OF AFLIBERCEPT TREATMENT ON CHOROIDAL THICKNESS IN REFRACTORY NAMD PATIENTS

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Syed, Adil [1 ,2 ]
Hong, Thomas [1 ,2 ]
Broadhead, Geoffrey K. [1 ,2 ]
Zhu, Meidong [2 ,3 ]
Chang, Andrew A. [1 ,2 ]
机构：
[1] Sydney Retina Clin & Day Surg, Sydney, NSW, Australia
[2] Sydney Inst Vis Sci, Sydney, NSW, Australia
[3] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2014年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
121
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] Brolucizumab Use in Treatment Resistant Neovascular Age Related Macular Degeneration (nAMD)
    Shortell, Justin
    Hill, Christine
    Thomas, Claire
    Peck, Travis
    Melamud, Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [2] Changes in Quality of Life Among Patients Treated with Aflibercept for neovascular Age-related Macular Degeneration (nAMD)
    Wijeyakumar, Wijeyanthy
    Hong, Thomas
    Broadhead, Geoffrey
    Li, Haitao
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] ENDOPHTHALMITIS FOLLOWING RANIBIZUMAB OR AFLIBERCEPT TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD): A RETROSPECTIVE US DATABASE ANALYSIS
    Vote, Brendan
    Dugel, Pravin
    Kelly, Simon P.
    Souied, Eric
    Ferreira, Alberto
    Milnes, Fran
    Clunas, Nathan
    Hashmonay, Ron
    Lu, Jingson
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 124 - 124
  • [4] Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
    Tan, Colin S.
    Ngo, Wei Kiong
    Chay, Isaac W.
    Ting, Dominic S.
    Sadda, SriniVas R.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 917 - 933
  • [5] Changes in Retinal Morphology in Neovascular Agerelated Macular Degeneration (nAMD) Patients Switched to Aflibercept
    Toth, Levente Arpad
    Zykova, Alyona
    Chakravarthy, Usha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
    Patel, Prem
    Sheth, Veeral
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [7] Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
    Ferrante, Nicola
    Ritrovato, Daniela
    Bitonti, Rossella
    Furneri, Gianluca
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [8] Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [9] Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
    Nicola Ferrante
    Daniela Ritrovato
    Rossella Bitonti
    Gianluca Furneri
    BMC Health Services Research, 22
  • [10] Two year outcome in treatment-naive patients with neovascular age-related macular degeneration (nAMD) using an individualized regimen of Aflibercept
    Barakat, A.
    Rufin, V.
    Tran, T. H. C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (07): : 603 - 610
12345